387 related articles for article (PubMed ID: 30071348)
1. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
Pellegrini S; Piemonti L; Sordi V
Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
3. Immunological applications of stem cells in type 1 diabetes.
Fiorina P; Voltarelli J; Zavazava N
Endocr Rev; 2011 Dec; 32(6):725-54. PubMed ID: 21862682
[TBL] [Abstract][Full Text] [Related]
4. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
Shen J; Cheng Y; Han Q; Mu Y; Han W
Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
[TBL] [Abstract][Full Text] [Related]
5. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
Quiskamp N; Bruin JE; Kieffer TJ
Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of induced pluripotent stem cells.
Okita K; Nagata N; Yamanaka S
Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
[No Abstract] [Full Text] [Related]
8. Cell differentiation: therapeutical challenges in diabetes.
Roche E; Vicente-Salar N; Arribas M; Paredes B
J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
[TBL] [Abstract][Full Text] [Related]
9. The Human Endocrine Pancreas: New Insights on Replacement and Regeneration.
Domínguez-Bendala J; Lanzoni G; Klein D; Álvarez-Cubela S; Pastori RL
Trends Endocrinol Metab; 2016 Mar; 27(3):153-162. PubMed ID: 26774512
[TBL] [Abstract][Full Text] [Related]
10. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
[TBL] [Abstract][Full Text] [Related]
11. Development of insulin-producing cells from primitive biologic precursors.
Evans-Molina C; Vestermark GL; Mirmira RG
Curr Opin Organ Transplant; 2009 Feb; 14(1):56-63. PubMed ID: 19337148
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic stem cells: differentiation options.
Rao MS; Reddy JK
Stem Cell Rev; 2005; 1(3):265-71. PubMed ID: 17142864
[No Abstract] [Full Text] [Related]
13. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
14. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
[TBL] [Abstract][Full Text] [Related]
15. Immunological Issues After Stem Cell-Based β Cell Replacement.
Sordi V; Pellegrini S; Piemonti L
Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
[TBL] [Abstract][Full Text] [Related]
16. Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.
Bartlett ST; Markmann JF; Johnson P; Korsgren O; Hering BJ; Scharp D; Kay TW; Bromberg J; Odorico JS; Weir GC; Bridges N; Kandaswamy R; Stock P; Friend P; Gotoh M; Cooper DK; Park CG; OʼConnell P; Stabler C; Matsumoto S; Ludwig B; Choudhary P; Kovatchev B; Rickels MR; Sykes M; Wood K; Kraemer K; Hwa A; Stanley E; Ricordi C; Zimmerman M; Greenstein J; Montanya E; Otonkoski T
Transplantation; 2016 Feb; 100 Suppl 2(Suppl 2):S1-44. PubMed ID: 26840096
[No Abstract] [Full Text] [Related]
17. Stem cells to restore insulin production and cure diabetes.
Sordi V; Pellegrini S; Krampera M; Marchetti P; Pessina A; Ciardelli G; Fadini G; Pintus C; Pantè G; Piemonti L
Nutr Metab Cardiovasc Dis; 2017 Jul; 27(7):583-600. PubMed ID: 28545927
[TBL] [Abstract][Full Text] [Related]
18. [From stem cells to functional beta cells in type 1 diabetes].
Engberg N; Hansson M; Madsen OD
Ugeskr Laeger; 2010 Sep; 172(38):2608-12. PubMed ID: 20920405
[TBL] [Abstract][Full Text] [Related]
19. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts.
Motté E; Szepessy E; Suenens K; Stangé G; Bomans M; Jacobs-Tulleneers-Thevissen D; Ling Z; Kroon E; Pipeleers D;
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E838-46. PubMed ID: 25205822
[TBL] [Abstract][Full Text] [Related]
20. Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients.
Khan J; Alexander A; Agrawal M; Ajazuddin ; Dubey SK; Siddique S; Saraf S; Saraf S
Curr Stem Cell Res Ther; 2019; 14(2):146-151. PubMed ID: 30280677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
